Frequently Asked Questions
The market is segmented based on Global Point of Care (POC) Urinalysis Market, By Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes), Product (Consumables, Systems) – Industry Trends and Forecast to 2030.
.
The Global Point Of Care Poc Urinalysis Market size was valued at USD 19.18 USD Billion in 2022.
The Global Point Of Care Poc Urinalysis Market is projected to grow at a CAGR of 7% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, F. Hoffmann, La Roche Ltd, BD, Siemens Healthcare Private Limited, BioRad Laboratories, Danaher, Sekisui Diagnostics, Trinity Biotech, bioMérieux, EKF Diagnostics, AccuBioTech Co., Instrumentation Laboratory, Beckman Coulter, PTS Diagnostics, Nova Biomedical, Chembio Diagnostics, Quidel Corporation, Sienco, .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
